Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

被引:235
|
作者
Bearcroft, CP
Perrett, D
Farthing, MJG
机构
[1] St Bartholomews & Royal London Sch Med & Dent, Dept Med, London E1 2AD, England
[2] Digest Dis Res Ctr, London E1 2AD, England
关键词
5-hydroxytryptamine; postprandial; diarrhoea predominant irritable bowel syndrome;
D O I
10.1136/gut.42.1.42
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-Increased concentrations of 5-hydroxytryptamine (5-HT) can be detected in the systemic circulation after a meal and may be involved in the physiological control of gastrointestinal motility. Abnormalities of 5-HT release after a meal might explain some of the postprandial symptoms associated with the irritable bowel syndrome (IBS). Aim-To investigate the effect of a standard meal on plasma 5-HT and urinary 5-hydroxyindole acetic acid (5-HIAA) concentrations in patients with diarrhoea predominant IBS and in healthy volunteers. Methods-After an overnight fast, six volunteers and five patients with IBS were given a carbohydrate-rich meal. Blood and urine samples were taken before and for four hours after the meal. Platelet-poor plasma 5-HT and urinary 5-HIAA were analysed by reversed phase high performance liquid chromatography with fluorometric detection. 5-HIAA was expressed as a ratio with urinary creatinine concentration, which was measured by spectrophotometry. Results-During the four hour postprandial period, 5-HT concentrations were significantly higher in patients with IBS than in healthy volunteers at 0.5 hours (p<0.05), 2 hours (p<0.05) and 2.5 hours (p<0.05). 5-HT was not detected in the plasma in the fasting state in patients or volunteers. Median peak 5-HT in patients with IBS (359 (198-796) nmol/l) was significantly greater than volunteers (83 (7-190)) (p<0.05). "Area under the curve)) for 5-HT detection was greater for patients with IBS (317 (138-771)) than for healthy volunteers (51 (4-129); p<0.05). The duration of the 5-HT peak was significantly longer in patients with IBS (3 (1-3) hours) than in the healthy volunteers (1 (1-1) hours; p<0.01). Postprandial urinary median 5-HIAA values in controls (5.6 (5.5-5.8) mu mol/mmol creatinine) and patients with IBS: (3.0 (2.5-6.8) mu mol/mmol creatinine) were not significantly different from preprandial Dentistry values (controls: 5.9 (5.5-6.6) mu mol/mmol creatinine; patients with IBS: (6.2 (2.4- 9.3) mu mol/mmol creatinine). Conclusion-These findings indicate that there may be a difference in the way that 5-HT is released in patients with diarrhoea predominant IBS, and could suggest a possible role for 5-HT in the postprandial symptoms of these patients.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 50 条
  • [31] Selective 5-hydroxytryptamine antagonism: A role in irritable bowel syndrome and functional dyspepsia?
    Maxton, DG
    Morris, J
    Whorwell, PJ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (04) : 595 - 599
  • [32] Sex hormonal status affects meal stimulated plasma 5-hydroxytryptamine (5-HT) levels in female patients with diarrhea predominant irritable bowel syndrome (IBS)
    Atkinson, W
    Houghton, LA
    Whorwell, P
    Whitaker, P
    GASTROENTEROLOGY, 2002, 122 (04) : A310 - A310
  • [33] CENTRAL 5-HYDROXYTRYPTAMINE (5HT) FUNCTION IN IRRITABLE-BOWEL-SYNDROME (IBS)
    GORARD, DA
    DEWSNAP, PA
    MEDBAK, SH
    LIBBY, GW
    FARTHING, MJG
    GASTROENTEROLOGY, 1993, 104 (04) : A827 - A827
  • [34] Sigmoid-colonic motility in health and irritable bowel syndrome: a role for 5-hydroxytryptamine
    Houghton, L. A.
    Atkinson, W.
    Lockhart, S.
    Fell, C.
    Whorwell, P. J.
    Keevil, B.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (09): : 724 - 731
  • [35] Cytokine profile in diarrhoea-predominant irritable bowel syndrome patients
    Sharma, S.
    Rana, S. V.
    Kaur, J.
    Bhasin, D. K.
    Ola, R. P.
    Singh, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 105 - 105
  • [36] Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?
    Chassany, O.
    Duracinsky, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (03) : 371 - 372
  • [37] Prevalence of microscopic colitis in patients with diarrhoea predominant irritable bowel syndrome
    Hilmi, I.
    Hartono, J.
    Pailoor, J.
    Mahadeva, S.
    Goh, K. L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 126 - 126
  • [38] Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome
    Durban, Ana
    Abellan, Juan J.
    Jimenez-Hernandez, Nuria
    Artacho, Alejandro
    Garrigues, Vicente
    Ortiz, Vicente
    Ponce, Julio
    Latorre, Amparo
    Moya, Andres
    FEMS MICROBIOLOGY ECOLOGY, 2013, 86 (03) : 581 - 589
  • [39] Decreased Basal and Postprandial Plasma 5-Hydroxytryptamine (5-HT) in Patients With Functional Dyspepsia (FD): A Pilot Study
    Cheung, Cynthia K.
    Lee, Yingying
    Chan, Yawen
    Cheong, Pui Kuan
    Law, Wai Tak W.
    Lee, Sau Fong
    Sung, Joseph J.
    Chan, Francis K. L.
    Wu, Justin C.
    GASTROENTEROLOGY, 2011, 140 (05) : S170 - S170
  • [40] Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea
    Money, Mary E.
    Walkowiak, Jaroslaw
    Virgilio, Chris
    Talley, Nicholas J.
    FRONTLINE GASTROENTEROLOGY, 2011, 2 (01) : 48 - 56